Health Care
Blog
Patient Ownership of Medical Records Leads to Personalized Healthcare
Individualization is absolutely driving current consumer trends, but American healthcare is falling behind the times. This isn’t because healthcare cannot be personalized, but because of a web of outdated assumptions and policies holding healthcare innovation back from reaching its full potential. Todd Rose, a high school dropout and Harvard professor, ...
Commentary
Under Government Health Care, The Doctor Won’t See You Now
In less than three weeks, the federal public health emergency for COVID-19 is set to expire. Some experts worry that the end of the emergency could unleash a flood of pent-up demand for health care—and add more stress to a health system already stretched thin. That’s because thousands of Americans—particularly seniors ...
Commentary
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
Health Care
PRI Senior Fellow Henry Miller quoted in the Hill on 4th Covid Shot
By Joseph Choi However, former FDA official Henry Miller said he was “bullish” to the idea of another booster dose. “I would love to see the summary that Pfizer presents to FDA,” said Miller. “But I don’t anticipate anything surprising. I mean we’ve been through this now with three doses. That is an extremely safe and very effective vaccine.”
Commentary
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
Commentary
Biden’s ‘Test to Treat’ COVID Plan: Good Sound Bite, Bad Policy
It ignores the risk of hazardous drug-drug interactions with the Pfizer pill. As someone who has closely followed and written extensively about the development of COVID-19 vaccines and drug treatments since the beginning of the pandemic, one pronouncement in President Joe Biden’s State of the Union speech raised red flags: “We’re also ready with ...
Commentary
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
Blog
L.A. School District and Teachers Union Keep Mask Mandate Despite Science
It is St. Patrick’s week, but there is little Irish luck for school kids in Los Angeles who are still being forced to wear masks, despite strong science showing that mask mandates result in little benefit. At the end of February, Governor Gavin Newsom finally relented and issued a statement ...
Commentary
Drug Pricing Reforms Should Expand Choice, Not Government Control
As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress ...
Commentary
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
Patient Ownership of Medical Records Leads to Personalized Healthcare
Individualization is absolutely driving current consumer trends, but American healthcare is falling behind the times. This isn’t because healthcare cannot be personalized, but because of a web of outdated assumptions and policies holding healthcare innovation back from reaching its full potential. Todd Rose, a high school dropout and Harvard professor, ...
Under Government Health Care, The Doctor Won’t See You Now
In less than three weeks, the federal public health emergency for COVID-19 is set to expire. Some experts worry that the end of the emergency could unleash a flood of pent-up demand for health care—and add more stress to a health system already stretched thin. That’s because thousands of Americans—particularly seniors ...
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
PRI Senior Fellow Henry Miller quoted in the Hill on 4th Covid Shot
By Joseph Choi However, former FDA official Henry Miller said he was “bullish” to the idea of another booster dose. “I would love to see the summary that Pfizer presents to FDA,” said Miller. “But I don’t anticipate anything surprising. I mean we’ve been through this now with three doses. That is an extremely safe and very effective vaccine.”
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
Biden’s ‘Test to Treat’ COVID Plan: Good Sound Bite, Bad Policy
It ignores the risk of hazardous drug-drug interactions with the Pfizer pill. As someone who has closely followed and written extensively about the development of COVID-19 vaccines and drug treatments since the beginning of the pandemic, one pronouncement in President Joe Biden’s State of the Union speech raised red flags: “We’re also ready with ...
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
L.A. School District and Teachers Union Keep Mask Mandate Despite Science
It is St. Patrick’s week, but there is little Irish luck for school kids in Los Angeles who are still being forced to wear masks, despite strong science showing that mask mandates result in little benefit. At the end of February, Governor Gavin Newsom finally relented and issued a statement ...
Drug Pricing Reforms Should Expand Choice, Not Government Control
As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress ...
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
